Pulmatrix secures FDA approval for Pulmazole phase 2 clinical study
Pulmazole phase 2 clinical study : Pulmatrix said that the US Food and Drug Administration (FDA) has authorized the Massachusetts-based
Continue readingCoverage of Global Pharma Industry News
Pulmazole phase 2 clinical study : Pulmatrix said that the US Food and Drug Administration (FDA) has authorized the Massachusetts-based
Continue readingDupixent FDA approval : Dupixent (dupilumab), an eczema drug the co-developed by Sanofi and Regeneron Pharmaceuticals, has been approved by the
Continue readingUK biopharma company AstraZeneca and Amgen have secured breakthrough therapy designation from the US Food and Drug Administration (FDA) for
Continue readingA new treatment was discovered unexpectedly for Gaucher’s Disease, an inherited enzyme disease, while carrying out a regular research on
Continue reading